# FDA 483 - Veronique Sebastian, M.D. - May 25, 2023

Source: https://www.globalkeysolutions.net/records/483/veronique-sebastian-md/907d665f-cd45-4f8f-ae69-b15c5c7a9829

> FDA 483 for Veronique Sebastian, M.D. on May 25, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Veronique Sebastian, M.D.
- Inspection Date: 2023-05-25
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Veronique Sebastian, M.D. in Oklahoma City, OK, revealed significant deficiencies in the conduct of clinical investigations. Observations included inadequate investigational drug disposition records and failure to conduct studies in accordance with the investigational plan. These findings indicate a need for improved oversight and adherence to study protocols, specifically regarding subject drug returns, dosing compliance, and timely performance of required examinations and laboratory assessments.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)
- [Veronica L. Bush](https://www.globalkeysolutions.net/people/veronica-l-bush/3582dd62-2cdf-4d1d-a78b-305c908ef9d5)
- [investigator](https://www.globalkeysolutions.net/people/corrine-m-carter/69e1be8c-1cd9-48d9-a08e-bf49060b94d6)

Company: https://www.globalkeysolutions.net/companies/veronique-sebastian-md/5f15ec7c-306b-4131-a541-a75182a99aab

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab